Coming Soon to eviCore Medical Oncology
Enhancements Coming October 1, 2021
New cancer treatments are entering the market at an unprecedented pace. Since 2018, the U.S. Food and Drug Administration (FDA) has approved more than 136 new cancer indicators, including 53 novel cancer drug entities. The FDA has launched a real-time oncology review program, under which it can review drug data in advance of a formal application, and oncology drugs can gain FDA approval within weeks of the application filing.
Effective October 1, 2021, the 1199SEIU Benefit Funds will make enhancements to our existing eviCore Medical Review Oncology programs. These changes will ensure that providers are guided to the most appropriate National Comprehensive Cancer Network (NCCN)-recommended treatments and are aware of all treatment options, while having administrative burdens reduced through the creation of authorization bundles. These enhancements will include the following:
- The medical oncology program will have a biosimilar first requirement;
- Supportive drug authorizations will be reviewed against known risks for the primary chemotherapy regimens consistent with NCCN guidance; and
- Radiology/chemotherapy bundles for medical oncology treatments will be created.
The Funds recognize there are a growing number of treatment options, combinations and additional lines of therapy that increase the complexity of making evidence-based determinations for treating members. We will continue to look for opportunities to help our providers access the most current and clinically relevant information to ensure that patients achieve optimal outcomes.
Please visit the sites below for educational materials related to each program enhancement and to register for an orientation session. To discuss these changes, call the Provider Relations Call Center at (646) 473-7160.
More Provider Connections
Ensure Faster Claims Processing by Using Correct Billing Codes
The National Correct Coding Initiative (NCCI), which promotes national correct coding methodologies and controls improper coding and incorrect payments for medical services, includes three types of edits: NCCI Procedure-to-Procedure Edits prevent inappropriate payment...
ClaimsXTen Select Is Now Lyric
The Benefit Funds’ claims auditing software ClaimsXten Select is now Lyric. Only the name—not the software—has changed. Lyric will continue to assess the appropriateness of professional and outpatient hospital claims against clinically based coding rules and edits,...
The Benefit Funds Credentialing Committee Seeks Board-certified Physicians
The Benefit Funds invite all board-certified participating providers with exemplary credentials and leadership qualities to join the 1199SEIU Benefit Funds Credentialing Committee. As a committee member, you would help ensure that the Benefit Funds maintain a...
The Benefit Funds Are Recredentialing Our Provider Network
The Benefit Funds are recredentialing our provider network and need your help to ensure that members have access to quality in-network healthcare providers. Please update your Council for Affordable Quality Healthcare (CAQH) application and your attestation form. You...
Important Alerts and Reminders
Aetna Choice POS II has been the wraparound network supplementing the Benefit Funds’ directly contracted network for coverage outside New York City since March 2, 2023. Aetna Choice POS II New York City provider locations are considered nonparticipating. Members must...